Hybrids of 4-aminoquinolines and adamantane as inhibitors of AChE
Alzheimer’s disease (AD) is an incurable and progressive neurodegenerative disorder that causes cognitive capabilities and memory loss and damage to brain functionality and structure. From diverse possibilities for drug development, the inhibition of acetylcholinesterase (AChE) remains as dominant t...
Saved in:
| Main Authors: | Komatović Katarina, Matošević Ana, Zlatović Mario, Sladić Dušan, Bosak Anita, Opsenica Dejan M. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Serbian Chemical Society
2025-01-01
|
| Series: | Journal of the Serbian Chemical Society |
| Subjects: | |
| Online Access: | https://doiserbia.nb.rs/img/doi/0352-5139/2025/0352-51392500014K.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease
by: Ana Matošević, et al.
Published: (2024-11-01) -
Tuning the Energy Levels of Adamantane by Boron Substitution
by: Aminu H. Yusuf, et al.
Published: (2025-04-01) -
Tuning of electronic, optical and lipophilic behaviours of adamantane through various substitutions
by: Aravindhan R, et al.
Published: (2025-01-01) -
Assessment of Potential Acetylcholinesterase Inhibitors: An In Silico Study
by: Nathaniel Ohiemi Amedu, et al.
Published: (2024-08-01) -
4-Aminoquinoline as a privileged scaffold for the design of leishmanicidal agents: structure–property relationships and key biological targets
by: Angel H. Romero, et al.
Published: (2025-01-01)